EUVIMEDEUVIMED entdecken
Open Access

Butyrolactol A enhances caspofungin efficacy via flippase inhibition in drug-resistant fungi

Xuefei Chen, H Diessel Duan, Michael J Hoy, Kalinka Koteva, Michaela Spitzer, Allison K Guitor, Emily Puumala, Aline A Fiebig, Guanggan Hu, Bonnie Yiu, Sommer Chou, Zhuyun Bian und 16 weitere

Cell · 2026-01 · 189 (2) · 620-639.e28

DOI: 10.1016/j.cell.2025.11.036 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell, 2026-01. Verfasst von Xuefei Chen und 27 weiteren Autor:innen. Beteiligte Einrichtung: David Braley Centre for Antibiotics Discovery, M.G. DeGroote Institute for Infectious Disease Research, Department of Biochemistry and Biomedical Sci…. Hauptthemen laut MEDLINE: Caspofungin, Antifungal Agents, Cryptococcus neoformans, Drug Resistance, Fungal. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 135 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NCI NIH HHS, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fungal infections cause millions of deaths annually and are challenging to treat due to limited therapeutic options and rising resistance. Cryptococci are intrinsically resistant to the latest generation of antifungals, echinocandins, while Candida auris, a notorious global threat, is also increasingly resistant. We performed a natural product screen to rescue caspofungin fungicidal activity against Cryptococcus neoformans H99 and identified butyrolactol A, which restores echinocandin efficacy against resistant fungal pathogens, including multidrug-resistant C. auris. Mode-of-action studies reveal that butyrolactol A inhibits the phospholipid flippase Apt1-Cdc50, blocking phospholipid transport. Cryo-electron microscopy analysis of the Apt1-butyrolactol A complex reveals that the flippase is trapped in a dead-end state. Apt1 inhibition disrupts membrane asymmetry, vesicular trafficking, and cytoskeletal organization, thereby enhancing echinocandin uptake and potency. This study identifies lipid flippases as promising antifungal targets and demonstrates the potential of revisiting natural products to expand the antifungal arsenal and combat resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CaspofunginAntifungal AgentsCryptococcus neoformansDrug Resistance, FungalMicrobial Sensitivity TestsFungal ProteinsCryoelectron MicroscopyCandida aurisEchinocandins

Stichwörter der Autor:innen

Apt1-Cdc50Candida aurisCryptococcusantifungalbutyrolactol Aechinocandinflippasefungal resistancenatural productsynergy

Substanzen

CaspofunginAntifungal AgentsFungal ProteinsEchinocandins

Autor:innen und Institutionen

  • David Braley Centre for Antibiotics Discovery, M.G. DeGroote Institute for Infectious Disease Research, Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON L8S 4K1, Canada.
  • Department of Structural Biology, Van Andel Institute, Grand Rapids, MI 49503, USA.
  • Department of Molecular Genetics and Microbiology, Duke University, Duke University Medical Center, Durham, NC 27710, USA.
  • Department of Molecular Genetics, University of Toronto, Toronto, ON M5G 1M1, Canada.
  • Michael Smith Laboratories, Department of Microbiology and Immunology, University of British Columbia, Vancouver, BC, Canada.
  • Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON L8S 4L8, Canada.

Förderung

  • NIAID NIH HHS
  • NCI NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • National Institutes of Health
  • Canada Research Chairs Program
  • Canadian Institutes of Health Research

Zitieren

APA

Chen, X., Duan, H. D., Hoy, M. J., Koteva, K., Spitzer, M., Guitor, A. K., Puumala, E., Fiebig, A. A., Hu, G., Yiu, B., Chou, S., Bian, Z., Choi, Y., Guo, A. B. Y., Wang, W., Sun, S., Robbins, N., Averette, A. F., Cook, M. A., …, & Wright, G. D. (2026). Butyrolactol A enhances caspofungin efficacy via flippase inhibition in drug-resistant fungi. Cell, 189(2), 620-639.e28. https://doi.org/10.1016/j.cell.2025.11.036

Vancouver

Chen X, Duan HD, Hoy MJ, Koteva K, Spitzer M, Guitor AK, et al. Butyrolactol A enhances caspofungin efficacy via flippase inhibition in drug-resistant fungi. Cell. 2026;189(2):620-639.e28. doi:10.1016/j.cell.2025.11.036

BibTeX
@article{Chen2026,
  author = {Chen, Xuefei and Duan, H Diessel and Hoy, Michael J and Koteva, Kalinka and Spitzer, Michaela and Guitor, Allison K and Puumala, Emily and Fiebig, Aline A and Hu, Guanggan and Yiu, Bonnie and Chou, Sommer and Bian, Zhuyun and Choi, Yeseul and Guo, Amelia Bing Ya and Wang, Wenliang and Sun, Sheng and Robbins, Nicole and Averette, Anna Floyd and Cook, Michael A and Truant, Ray and MacNeil, Lesley T and Brown, Eric D and Kronstad, James W and Coombes, Brian K and Cowen, Leah E and Heitman, Joseph and Li, Huilin and Wright, Gerard D},
  title = {Butyrolactol A enhances caspofungin efficacy via flippase inhibition in drug-resistant fungi},
  journal = {Cell},
  year = {2026},
  volume = {189},
  number = {2},
  pages = {620--639.e28},
  doi = {10.1016/j.cell.2025.11.036}
}
Kostenlos starten →